Healthy Inc > Blog > Blog

Category: Blog

Your blog category

Posted on:

What is the use of Artemether and Lumefantrine dispersible tablet?

In the pharmaceutical industry, Artemether and Lumefantrine dispersible tablets (standardized at 20 mg / 120 mg) are the specialized pediatric formulation of the gold-standard Artemisinin-based Combination Therapy (ACT). As a pharmacist, I view the “dispersible” delivery system as a life-saving innovation designed to ensure accurate dosing and rapid absorption in infants and children, who are the most vulnerable to malaria.

Primary Clinical Uses

  • Pediatric Uncomplicated Malaria: Specifically indicated for the treatment of acute, uncomplicated malaria caused by Plasmodium falciparum in infants and children weighing between 5 kg and 35 kg.

  • Chloroquine-Resistant Strains: First-line defense in regions where malaria parasites have developed resistance to older monotherapies.

  • Rapid Parasite Clearance: Used to quickly reduce the parasite biomass in the blood to prevent the progression of uncomplicated malaria into life-threatening severe or cerebral malaria.

Mechanism of Action

This combination employs a “dual-speed” parasiticidal effect:

Artemether: A fast-acting component that generates reactive free radicals. These radicals damage the parasite’s proteins and membranes, providing an immediate “knockdown” of the infection.

Lumefantrine: A long-acting component that clears any remaining parasites over several days. Its presence in the blood prevents the infection from returning (recrudescence) after the short-lived Artemether has cleared.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, the dispersible tablet is a technically demanding product that serves a massive public health niche:

  • Dispersibility Standards: As a WHO-GMP quality parameter, these tablets must disintegrate in a small amount of water or milk within 1 to 2 minutes to form a smooth suspension, ensuring the child receives the full dose without the risk of choking.

  • Taste-Masking Technology: Artemether and Lumefantrine are naturally very bitter. For a manufacturing firm, the use of advanced sweetening and flavoring agents (such as cherry or strawberry) is essential to prevent the child from spitting out the medicine.

  • Stabilization for Tropical Climates: Both APIs, particularly Artemether, are sensitive to heat and moisture. We utilize Alu-Alu blister packaging to ensure a 24-month shelf life in Zone IVb environments (hot and humid), common in Africa and Southeast Asia.

  • Global Health Tenders: These are high-volume essential medicines for international NGOs, UNICEF, and the Global Fund. Our Mumbai facility is optimized for the high-capacity production and the rigorous CTD/eCTD documentation required for these global contracts.

Artemether & Lumefantrine Tablets

Posted on:

What is the use of Artemether and Lumefantrine tablets?

In the pharmaceutical industry, Artemether and Lumefantrine tablets (commonly in 20 mg/120 mg or 80 mg/480 mg strengths) represent the gold standard in Artemisinin-based Combination Therapy (ACT). As a pharmacist, I view this specific fixed-dose combination (FDC) as the most critical frontline defense against multi-drug resistant malaria.

Primary Clinical Uses

  • Uncomplicated Malaria: Indicated for the treatment of acute, uncomplicated malaria infections caused by Plasmodium falciparum, including infections acquired in chloroquine-resistant areas.

  • Pediatric and Adult Populations: Used widely across all age groups (standardized by weight) to ensure rapid clearance of parasites from the blood.

  • Stand-by Emergency Treatment: Often carried by travelers to malaria-endemic regions as a self-administered emergency treatment when medical facilities are unavailable.

Mechanism of Action

This combination provides a dual-phase attack on the malaria parasite:

Artemether: A semi-synthetic derivative of artemisinin. It acts rapidly to provide a fast “knockdown” of the parasite load by generating reactive free radicals that disrupt the parasite’s membrane and proteins.

Lumefantrine: A long-acting fluorene derivative. It acts more slowly but stays in the system longer to clear any residual parasites that survived the initial Artemether burst, preventing recrudescence (relapse).

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Artemether-Lumefantrine is a high-precision product requiring stringent quality controls:

  • Fixed-Dose Combination (FDC) Stability: Artemether is a relatively unstable molecule sensitive to heat and moisture. As a WHO-GMP manufacturer, we utilize specialized granulation processes and Alu-Alu blister packaging to ensure stability, particularly for export to the high-heat environments of Africa and Southeast Asia.

  • Bioavailability: Lumefantrine has highly variable absorption. Our formulation includes specific excipients to ensure consistent absorption, especially when taken with fatty foods, which is a critical clinical requirement.

  • Global Health Tenders: This is a high-volume item for international NGOs, UNICEF, and the Global Fund. Our Mumbai-based facility is optimized to meet the massive demand for these tenders with full CTD/eCTD Dossier support.

  • Pediatric Dispersible Tablets: We also focus on dispersible formulations with pleasant flavoring to ensure easy administration and compliance in children, which is vital for reducing child mortality.

Artemether & Lumefantrine Tablets

Posted on:

What is the use of amodiaquine hydrochloride?

In the pharmaceutical industry, Amodiaquine Hydrochloride is a 4-aminoquinoline derivative that serves as a potent antimalarial agent. As a pharmacist, I characterize Amodiaquine as a critical fast-acting blood schizontocide, particularly indispensable in regions where there is established resistance to older molecules like Chloroquine.

Primary Clinical Uses

  • Treatment of Plasmodium falciparum: It is highly effective against the asexual erythrocytic stages of P. falciparum.

  • ACT Combination Therapy: In modern medicine, Amodiaquine is rarely used as a monotherapy. It is most commonly used in Artemisinin-based Combination Therapy (ACT), specifically as Artesunate + Amodiaquine (AS+AQ), which is a WHO-recommended first-line treatment for uncomplicated malaria.

  • Seasonal Malaria Chemoprevention (SMC): Used in combination with Sulfadoxine-Pyrimethamine (SP) for the intermittent administration of full treatment courses during the malaria season to prevent illness in children.

Mechanism of Action

Amodiaquine acts primarily by inhibiting the polymerization of hemozoin. When the malaria parasite digests the host’s hemoglobin, it releases toxic free heme. Amodiaquine enters the parasite’s food vacuole and prevents the detoxification of this heme into non-toxic hemozoin crystals. The resulting accumulation of free heme is toxic to the parasite, leading to its rapid destruction.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Amodiaquine is a high-priority molecule for public health tenders and international B2B supply:

  • Fixed-Dose Combination (FDC): The primary manufacturing challenge is creating stable FDCs with Artesunate. Since Artesunate is sensitive to moisture, we utilize specialized bilayer tablet technology or advanced granulation techniques to ensure both APIs remain stable.

  • Standardization: We ensure the API meets BP/USP/IP specifications, with a focus on controlling the impurity profile to minimize the risk of rare but serious side effects like agranulocytosis or hepatotoxicity.

  • Global Export Niche: Amodiaquine is a staple for the African and Southeast Asian markets. As a WHO-GMP manufacturer, our facility in Mumbai is optimized for high-volume production for NGO and government tenders (e.g., Global Fund, USAID).

  • Regulatory Readiness: We provide the CTD/eCTD Dossiers and stability data required for registration in malaria-endemic zones, ensuring the product maintains its potency in Zone IVb (hot and humid) conditions.

Amodiaquine Tablets

Posted on:

What is losartan potassium and amlodipine besylate tablets used for?

In the pharmaceutical industry, the combination of Losartan Potassium and Amlodipine Besylate is a high-performance fixed-dose combination (FDC) used to manage hypertension (high blood pressure). As a pharmacist, I view this pairing as a premier therapeutic strategy because it targets the cardiovascular system through two distinct, non-overlapping pathways, providing a comprehensive reduction in vascular resistance.

Primary Clinical Uses

  • Essential Hypertension: Specifically indicated for patients whose blood pressure is not adequately controlled with monotherapy or as initial therapy in patients who require multiple drugs to achieve blood pressure goals.

  • Cardiovascular Protection: Indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (LVH).

  • Renal Protection in Diabetes: While primarily for blood pressure, the Losartan component offers significant renoprotective benefits for Type 2 diabetic patients with nephropathy.

Mechanism of Action

This FDC utilizes a “double-blockade” approach to relax blood vessels:

Losartan Potassium (Angiotensin II Receptor Blocker – ARB): It selectively blocks the binding of Angiotensin II to the $AT_1$ receptor found in many tissues (e.g., vascular smooth muscle, adrenal gland). This inhibits the vasoconstricting and aldosterone-secreting effects of Angiotensin II.

Amlodipine Besylate (Calcium Channel Blocker – CCB): It inhibits the influx of calcium ions into vascular smooth muscle and cardiac muscle. This results in direct peripheral arterial vasodilation.

The synergy here is clinical: Amlodipine is a potent vasodilator, but it can sometimes cause peripheral edema (swelling). Losartan helps counteract this by promoting venous dilation and improving fluid balance, leading to better patient tolerance.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Losartan + Amlodipine is a staple of chronic care portfolios:

  • API Compatibility: As a WHO-GMP manufacturer, we ensure the stability of the Losartan Potassium (a salt) and Amlodipine Besylate (a salt) within a single matrix. Our formulation prevents any drug-drug degradation over the product’s shelf life.

  • Moisture Protection: Losartan is somewhat hygroscopic. We utilize Alu-Alu blister packaging to ensure the tablets remain stable during export to hot and humid Zone IVb climates.

  • Global Demand: Hypertension is a global epidemic. This FDC is a high-volume item for B2B marketplaces and hospital tenders in Southeast Asia, Africa, and the Middle East.

  • Regulatory Support: We provide comprehensive CTD/eCTD Dossiers and bioequivalence data to support our international partners in obtaining local health authority approvals.

Amlodipine besylate with Losartan potassium Tablets

 

Posted on:

What is losartan potassium and amlodipine besylate tablets used for?

In the pharmaceutical industry, the combination of Losartan Potassium and Amlodipine Besylate is a high-performance fixed-dose combination (FDC) used to manage hypertension (high blood pressure). As a pharmacist, I view this pairing as a premier therapeutic strategy because it targets the cardiovascular system through two distinct, non-overlapping pathways, providing a comprehensive reduction in vascular resistance.

Primary Clinical Uses

  • Essential Hypertension: Specifically indicated for patients whose blood pressure is not adequately controlled with monotherapy or as initial therapy in patients who require multiple drugs to achieve blood pressure goals.

  • Cardiovascular Protection: Indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (LVH).

  • Renal Protection in Diabetes: While primarily for blood pressure, the Losartan component offers significant renoprotective benefits for Type 2 diabetic patients with nephropathy.

Mechanism of Action

This FDC utilizes a “double-blockade” approach to relax blood vessels:

Losartan Potassium (Angiotensin II Receptor Blocker – ARB): It selectively blocks the binding of Angiotensin II to the $AT_1$ receptor found in many tissues (e.g., vascular smooth muscle, adrenal gland). This inhibits the vasoconstricting and aldosterone-secreting effects of Angiotensin II.

Amlodipine Besylate (Calcium Channel Blocker – CCB): It inhibits the influx of calcium ions into vascular smooth muscle and cardiac muscle. This results in direct peripheral arterial vasodilation.

The synergy here is clinical: Amlodipine is a potent vasodilator, but it can sometimes cause peripheral edema (swelling). Losartan helps counteract this by promoting venous dilation and improving fluid balance, leading to better patient tolerance.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Losartan + Amlodipine is a staple of chronic care portfolios:

  • API Compatibility: As a WHO-GMP manufacturer, we ensure the stability of the Losartan Potassium (a salt) and Amlodipine Besylate (a salt) within a single matrix. Our formulation prevents any drug-drug degradation over the product’s shelf life.

  • Moisture Protection: Losartan is somewhat hygroscopic. We utilize Alu-Alu blister packaging to ensure the tablets remain stable during export to hot and humid Zone IVb climates.

  • Global Demand: Hypertension is a global epidemic. This FDC is a high-volume item for B2B marketplaces and hospital tenders in Southeast Asia, Africa, and the Middle East.

  • Regulatory Support: We provide comprehensive CTD/eCTD Dossiers and bioequivalence data to support our international partners in obtaining local health authority approvals.

Amlodipine besylate with Losartan potassium Tablets

Posted on:

What is the use of amlodipine and enalapril maleate tablets?

In the pharmaceutical industry, the fixed-dose combination (FDC) of Amlodipine and Enalapril Maleate is a potent “dual-action” antihypertensive. As a pharmacist, I view this combination as a strategic therapeutic intervention that utilizes two different mechanisms to achieve superior blood pressure control with a lower incidence of side effects compared to high-dose monotherapy.

Primary Clinical Uses

  • Essential Hypertension: Indicated for patients whose blood pressure is not adequately controlled by Amlodipine or Enalapril alone.

  • Cardiovascular Risk Reduction: By maintaining stable blood pressure, this combination reduces the long-term risk of stroke, myocardial infarction (heart attack), and renal failure.

  • Chronic Stable Angina: The Amlodipine component helps manage chest pain, while Enalapril provides protective benefits for the vascular endothelium.

Mechanism of Action

This FDC offers a synergistic approach to vasodilation:

Amlodipine (Calcium Channel Blocker): Inhibits the influx of calcium ions into vascular smooth muscle, causing direct peripheral arterial vasodilation. This reduces total peripheral resistance.

Enalapril Maleate (ACE Inhibitor): A prodrug converted to Enalaprilat, which inhibits the Angiotensin-Converting Enzyme (ACE). This prevents the formation of Angiotensin II (a powerful vasoconstrictor) and reduces Aldosterone secretion, leading to decreased sodium and water retention.

By combining these, Enalapril helps counteract the compensatory activation of the Renin-Angiotensin System that can sometimes occur with Amlodipine use, and it can also reduce the risk of peripheral edema (ankle swelling) often associated with CCBs.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing standpoint, this combination requires advanced stability protocols to ensure the integrity of two different active ingredients:

  • Bilayer or Uniform Compression: Depending on the formulation strategy, these may be produced as bilayer tablets to prevent physical-chemical interactions between the two APIs, ensuring optimal shelf-life.

  • Moisture Sensitivity: Enalapril Maleate is particularly sensitive to moisture. As a WHO-GMP manufacturer, we utilize high-barrier Alu-Alu blister packaging to protect the tablets, especially for export to hot and humid Zone IVb climates.

  • Regulatory Dossiers: We provide comprehensive CTD/eCTD Dossiers including Bioequivalence (BE) studies to prove that the FDC performs as effectively as the individual components taken together.

  • Export Strategy: This combination is a high-value item for B2B marketplaces and international tenders in regions with high cardiovascular disease prevalence, such as Southeast Asia, Africa, and the CIS.

Top 30 Brands of Amlodipine + Enalapril Maleate Tablets

Posted on:

Can taking lisinopril cause dehydration?

In the pharmaceutical industry, Lisinopril tablets (ranging from 2.5 mg to 40 mg) are a mainstay ACE (Angiotensin-Converting Enzyme) Inhibitor used to manage hypertension and heart failure. As a pharmacist, I must clarify that while Lisinopril does not directly “cause” dehydration in the same way a diuretic (like Furosemide) does, its interaction with the body’s fluid and electrolyte balance is complex and requires careful monitoring.

The Relationship Between Lisinopril and Fluid Balance

Lisinopril itself is not a dehydrating agent. However, it can influence hydration status and electrolyte levels in the following ways:

  • Potassium Retention: Unlike medications that cause fluid loss, Lisinopril can cause the body to retain potassium (hyperkalemia). This change in electrolyte balance can sometimes be mistaken for symptoms of dehydration, such as muscle weakness or confusion.

  • The “Dual-Drug” Factor: Lisinopril is very frequently prescribed in combination with a diuretic (like Hydrochlorothiazide). If you are taking a combination pill or both medications separately, the diuretic is the component likely causing increased urination and potential dehydration.

  • Reduced Thirst Response: Some ACE inhibitors can subtly alter the thirst mechanism in the brain, though this is clinically rare.

  • Risk of Hypotension: If a patient becomes dehydrated due to other causes (fever, sweating, vomiting), taking Lisinopril can cause blood pressure to drop significantly lower than intended, increasing the risk of fainting or kidney strain.

Mechanism of Action

Lisinopril works by inhibiting the enzyme that converts Angiotensin I to Angiotensin II. Angiotensin II is a potent vasoconstrictor that also stimulates the release of Aldosterone. By reducing Aldosterone levels, Lisinopril decreases sodium and water retention in the kidneys. While this helps lower blood pressure, it does not typically lead to the “volume depletion” seen with water pills.

Shutterstock

The Manufacturer’s Perspective: Safety & Compliance

From a manufacturing and export perspective, providing clear technical guidance on fluid management is essential for patient safety:

  • Advisory Labeling: As a WHO-GMP manufacturer, we ensure that product inserts include clear warnings about monitoring renal function and potassium levels, especially in hot climates (Zone IVb) where natural dehydration is common.

  • Drug-Drug Interactions: We emphasize the importance of identifying whether the patient is on a “Co-Lisinopril” (Lisinopril + HCTZ) formulation, as the manufacturing specifications and clinical precautions for combination therapies differ from monotherapy.

  • Market Education: For our B2B partners in regions like Africa and the Middle East, we provide technical data on managing “first-dose hypotension,” which is more likely to occur in patients who are already fluid-depleted.

Lisinopril Tablets

 

Posted on:

What is an amlodipine tablet good for?

In the pharmaceutical industry, Amlodipine tablets (available in 2.5 mg, 5 mg, and 10 mg) are a leading long-acting calcium channel blocker (CCB) of the dihydropyridine class. As a pharmacist, I consider Amlodipine a foundational treatment for cardiovascular health due to its high bioavailability and consistent 24-hour efficacy.

Primary Clinical Uses

  • Hypertension (High Blood Pressure): It is a first-line therapy to lower blood pressure, which significantly reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.

  • Chronic Stable Angina: Used to prevent the chest pain associated with coronary artery disease by improving blood flow to the heart muscle.

  • Vasospastic Angina (Prinzmetal’s Angina): Specifically indicated for treating chest pain caused by spasms of the coronary arteries.

  • Coronary Artery Disease (CAD): In patients with recently documented CAD by angiography, Amlodipine is used to reduce the risk of hospitalization for angina and to reduce the risk of a coronary revascularization procedure.

Mechanism of Action

Amlodipine works by inhibiting the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle. It specifically targets “L-type” calcium channels. By preventing calcium from entering these cells, it causes the blood vessels to relax and dilate (vasodilation). This action decreases total peripheral resistance (afterload), which lowers blood pressure and reduces the workload on the heart.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Amlodipine Besylate is a robust, high-demand molecule that requires technical precision:

  • Salt Selection (Besylate vs. Maleate): We primarily manufacture the Besylate salt due to its superior stability and compatibility profile during the compression process, ensuring a longer shelf life for international transit.

  • Photo-Stability: Amlodipine is sensitive to light. As a WHO-GMP manufacturer, we utilize opaque blister packaging and light-resistant coating techniques to maintain the integrity of the active pharmaceutical ingredient (API).

  • Global Export Reach: Because hypertension is a global health priority, Amlodipine is a staple for our B2B partners and government tenders. Our facility in Mumbai is optimized for the high-capacity production required for these recurring global orders.

  • Regulatory Compliance: We provide comprehensive CTD/eCTD Dossiers, including comparative dissolution studies, to ensure our partners meet the bioequivalence requirements for registration in markets across Africa, the Middle East, and Southeast Asia.

Amlodipine Tablet

Posted on:

What is amitriptyline hydrochloride tablets used for?

In the pharmaceutical industry, Amitriptyline Hydrochloride tablets (commonly available in 10 mg, 25 mg, 50 mg, and 75 mg) are a foundational Tricyclic Antidepressant (TCA). As a pharmacist, I categorize Amitriptyline as a versatile “multi-channel” medication; while originally developed for psychiatry, its most frequent contemporary applications are in the management of chronic pain and neurological disorders.

Primary Clinical Uses

  • Major Depressive Disorder (MDD): Particularly effective for depression associated with anxiety and sleep disturbances due to its sedative properties.

  • Neuropathic Pain: A first-line treatment for chronic nerve pain, including diabetic neuropathy, post-herpetic neuralgia, and sciatica.

  • Prophylaxis of Migraine: Widely prescribed as a preventive measure to reduce the frequency and severity of chronic tension-type headaches and migraines.

  • Fibromyalgia: Used to manage the widespread musculoskeletal pain and sleep interference associated with fibromyalgia.

  • Nocturnal Enuresis: Occasionally used in pediatric medicine for the treatment of bedwetting when other therapies have failed.Mechanism of Action

Amitriptyline works by increasing the synaptic concentration of neurotransmitters in the Central Nervous System (CNS). It inhibits the reuptake of Serotonin and Norepinephrine at the presynaptic neuronal membrane. By keeping these chemicals in the synaptic cleft longer, it enhances mood and significantly raises the body’s pain threshold. It also possesses anticholinergic and antihistaminic effects, which contribute to its sedative properties.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Amitriptyline is a high-demand CNS molecule:

  • Precision Dosing: Because TCAs require careful titration (starting at low doses like 10 mg to minimize side effects), manufacturing accuracy and content uniformity are critical WHO-GMP parameters.

  • Stability for Export: Amitriptyline Hydrochloride is relatively stable, but as a manufacturing firm, we ensure our formulations are protected from light and moisture, utilizing specialized packaging for export to varied climatic zones (Zone IVb).

  • Global Reach: This molecule is a staple for B2B pharmaceutical distributors and hospital tenders worldwide. Our Mumbai-based export hub provides comprehensive CTD/eCTD Dossiers to facilitate fast-track registration in international markets.

  • B2B Customization: We offer bulk supply and private labeling for international partners looking to expand their psychiatric and pain management portfolios.

Amitriptyline Hydrochloride Tablet

Posted on:

What are amiodarone tablets used for?

In the pharmaceutical industry, Amiodarone tablets (typically available in 100 mg and 200 mg) are classified as a Class III anti-arrhythmic agent. As a pharmacist, I consider Amiodarone a “broad-spectrum” anti-arrhythmic because, while it is primarily a potassium channel blocker, it also exhibits characteristics of all four Vaughan-Williams classes, making it exceptionally potent for complex cardiac rhythms.

Primary Clinical Uses

  • Ventricular Arrhythmias: Indicated for the treatment of life-threatening recurrent ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT).

  • Atrial Fibrillation (AFib): Widely used for rhythm control to convert AFib to a normal sinus rhythm and to maintain that rhythm over the long term.

  • Supraventricular Tachycardias (SVT): Effective in managing various forms of SVT, particularly in patients with impaired left ventricular function where other agents might be contraindicated.

    Refractory Cases: Often utilized when other anti-arrhythmic medications have failed or are not tolerated by the patient.

    Mechanism of Action

Amiodarone’s primary action is the blockade of potassium channels, which prolongs the action potential duration and the refractory period in myocardial tissue (Class III effect). However, it also:

Inhibits inactivated sodium channels (Class I effect).

Exhibits non-competitive alpha- and beta-adrenergic inhibition (Class II effect).

Exhibits weak calcium channel blocking activity (Class IV effect).

This comprehensive blockade helps stabilize the cardiac membrane and slow the conduction of electrical impulses that cause irregular heartbeats.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Amiodarone 200 mg is a critical chronic care molecule requiring strict quality oversight:

  • Lipid Solubility & Bioavailability: Amiodarone is highly lipophilic, which leads to a very long half-life (up to 60 days). As a WHO-GMP manufacturer, we ensure precise formulation to maintain consistent dissolution profiles, which is vital given the drug’s narrow therapeutic index.

  • Photosensitivity & Packaging: The molecule is sensitive to light. We utilize amber-colored PVC or Alu-Alu blister packaging to protect the integrity of the tablets during transit and storage in various global climates.

  • Global Export Niche: Amiodarone is a high-value export item for B2B partners supplying cardiology clinics and hospitals. Our Mumbai-based facility provides the necessary CTD/eCTD Dossiers to facilitate registration in highly regulated and semi-regulated markets.

  • Technical Support: We provide comprehensive stability data for Zone IVb, ensuring that our international partners in Africa, SE Asia, and Latin America receive a product that maintains its potency in hot and humid conditions.

Amiodarone Tablet

Add to cart